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Abstract Recombinant pro-Der p 1 expressed in yeast Pichia
pastoris was convertible into the prosequence-removed mature
Der p 1 with full activities of cysteine protease and IgE-binding
with or without N-glycosylation of the mature sequence as well
as pro-Der f 1. The active recombinant variants will be the basis
for various future studies. The major N-terminus of pro-Der p 1
with low proteolytic activity was the putative signal-cleavage
site, while that of pro-Der f 1 contained not only the equivalent
site but also 21 residues downstream, and pro-Der f 1 retained
signi¢cant activity. Contribution of the N-terminal region of
the Der p 1 prosequence including an N-glycosylation motif
on e¡ective inhibition of proteolytic activity of pro-Der p 1
was suggested.
( 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
Key words: Recombinant major house dust mite group 1
allergen; Maturation; Prosequence; N-Glycosylation;
Cysteine protease; IgE-binding
1. Introduction
House dust mites of the Dermatophagoides species (Derma-
tophagoides pteronyssinus and Dermatophagoides farinae) are
the most important causative factor associated with various
allergic diseases among all the indoor allergens [1^3]. Group 1
(Der p 1 and Der f 1) and group 2 (Der p 2 and Der f 2)
allergens are considered the major house dust mite allergens
[4^7]. IgE-binding activity for both group 1 and group 2 al-
lergens is detected in the majority of sera from patients aller-
gic to house dust mites. Group 1 allergens, which belong to
the papain-like cysteine protease family, are mainly found in
mite feces and are thought to function as digestive enzymes in
the intestine of mites [8^10]. IgE-binding to the group 1 aller-
gens is highly dependent on the tertiary structure of the aller-
gens [5,11,12]. Recently, the cysteine protease activity of a
group 1 allergen from D. pteronyssinus, Der p 1, has been
proposed to be involved in the pathogenesis of allergy [13^
17]. Therefore, enzymatically and immunologically active re-
combinant group 1 allergens with structures equivalent to the
natural ones will be useful tools for diagnosis, standardized
allergen-speci¢c immunotherapy (AIT) [18^20], and various
studies, including the analysis of conformation-dependent
IgE epitopes [21^27], determination of tertiary structure [28],
allergen engineering for safer and more e¡ective AIT [18^
20,23^26,29], resolving the relationship between the enzymatic
activity and pathogenesis [13^17,30], and so on.
The cDNAs for the mite group 1 allergens and their iso-
forms have been cloned [31^34]. They encode the preprose-
quence at the N-terminus of the mature sequence. Recently,
we have developed e⁄cient systems to prepare recombinant
forms of the group 1 allergen from D. farinae, Der f 1, which
is expressed abundantly in methylotrophic yeast Pichia pasto-
ris [35,36] and bacteria [37], and demonstrated their mature
protease activity, IgE reactivity, and an apparent molecular
weight equivalency to that of natural Der f 1. On the other
hand, preparation of recombinant mature Der p 1 with equiv-
alent properties in terms of activities and molecular weight
has not been reported, although enzymatically inactive pro-
Der p 1 was reported by some researchers [38^40], and highly
glycosylated mature Der p 1 with enzymatic and allergenic
activities but with a broad apparent molecular weight much
higher than natural Der p 1 was reported recently [41].
We show that recombinant proforms of Der p 1 as well as
those of Der f 1 expressed in yeast P. pastoris with or without
N-glycosylation of the mature sequence are convertible into
the prosequence-removed mature forms with full cysteine pro-
tease activity. IgE reactivities of the recombinant mature
forms were also equivalent to those of natural ones. This is
the ¢rst report that demonstrates the preparation of recombi-
nant mature Der p 1, which has no yeast-derived N-glycosyl-
ation and retains an apparent molecular weight equivalency to
natural Der p 1, with full enzymatic and IgE-binding activ-
ities. Moreover, we compare the properties of the recombi-
nant pro- and mature forms of the two homologous allergens
Der p 1 and Der f 1 and discuss the role of the N-terminal
region of the prosequence in the maturation and inhibition of
proteolytic activity of the recombinant proforms of the house
dust mite group 1 allergens.
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2. Materials and methods
2.1. Cloning of cDNA coding for prepro-Der p 1 and prepro-Der f 1
The total RNA from cultured mites was prepared, and the cDNA
fragments of prepro-Der p 1 and prepro-Der f 1 were synthesized and
ampli¢ed by reverse transcription- polymerase chain reaction (RT-
PCR). The PCR primers were designed on the basis of previously
described cDNA sequences [33,34]. The cDNA fragments were sub-
cloned into pBluescript II SK+ (Stratagene, La Jolla, CA, USA) or
pCR2.1-TOPO (Invitrogen, Groningen, The Netherlands) and se-
quenced by a DNA sequencer (ABI Prism 377, Applied Biosystems,
Foster City, CA, USA).
2.2. Construction of expression vectors encoding prepro-Der p 1,
prepro-Der f 1, and their mutants
A BamHI site and a NotI site were added to the 5P and 3P termini,
respectively, of each open reading frame (ORF) for prepro-Der p 1
and prepro-Der f 1 by PCR. Vectors for expression in the methylo-
trophic yeast P. pastoris encoding the prepro-Der p 1-WT and prepro-
Der f 1-WT, each of which has the intact wild-type sequence, were
constructed by insertion of the PCR-ampli¢ed cDNA fragments di-
gested with BamHI and NotI to the BamHI/NotI site of pPIC3.5
(Invitrogen). Expression vectors encoding for mutants whose N-gly-
cosylation motifs within the mature sequences are disrupted, prepro-
Der p 1-N52Q and prepro-Der f 1-N53Q, were constructed by site-
directed mutagenesis. It was con¢rmed that the inserted sequences
encoded the correct amino acid sequences by DNA sequencing.
2.3. Expression of prepro-Der p 1, prepro-Der f 1, and their mutants in
P. pastoris
The method was as described previously [35] with minor modi¢ca-
tions. Brie£y, the expression vectors were introduced into P. pastoris
GS115 cells by electroporation. Transfectants in which the locus of
the genomic alcohol oxidase gene was homologously recombined with
the linearized vector DNA were selected. The transfectants were cul-
tured at 30‡C in 5 ml of YPD. Four milliliters of the one or two
overnight full-growth culture was inoculated in 400 ml of BMGY
and cultured for 24 h. The cells were pelleted by centrifugation, re-
suspended in 80 ml of BMMY and cultured for an additional 72^96 h
with addition of methanol to the culture every 24 h to maintain the
continuous expression of the recombinant products. The culture
supernatant was harvested by centrifugation. The culture superna-
tants, to which a 1/5-volume of 0.5 M Tris^HCL (pH 9.0) containing
0.1% NaN3 was added, were concentrated by ammonium sulfate-pre-
cipitation. The concentrations of ammonium sulfate were 80%-satu-
ration for pro-Der p 1-WT and pro-Der f 1-WT, and 50%-saturation
for pro-Der p 1-N52Q and pro-Der f 1-53Q. The precipitates were
dissolved in 50 mM Tris^HCL (pH 9.0) containing 0.01% NaN3 at 1/
20 volume of the original culture supernatants.
2.4. Maturation of pro-Der p 1, pro-Der f 1, and their mutants, and
puri¢cation of the pro- and mature forms
The method was as described previously [35] with minor modi¢ca-
tions. Brie£y, the supernatants concentrated by ammonium sulfate-
precipitation were dialyzed against 100 mM sodium acetate bu¡er (pH
4.0) for 3 h at room temperature and an additional 24^48 h at 4‡C.
After this activation process, the recombinant products were subjected
to anion exchange column chromatography after dialysis against a
bu¡er for the chromatography. Purities of the fractions of NaCl-gra-
dient elution (0^400 mm) were checked by sodium dodecyl sulfate^
polyacrylamide gel electrophoresis (SDS^PAGE). The fractions con-
taining pure recombinant proteins were mixed, aliquoted, and stored
at 380‡C. Protein concentrations were determined by the Bradford’s
procedure using a protein assay kit (Bio-Rad, Richmond, CA, USA)
with bovine IgG (Bio-Rad) as the standard. The recombinant pro-
forms of Der p 1 and Der f 1 were puri¢ed by the same methods as
the mature forms but without the activation process of dialysis against
the acidic bu¡er.
2.5. Protein sequencing
The method was as described previously [42,43]. The samples were
subjected to SDS^PAGE and electroblotted onto membranes. Before
the SDS^PAGE, the samples were boiled under reducing conditions
with dithioerythritol in the sample bu¡er, and then the cysteine resi-
dues were alkylated [43]. The membranes were stained with Coomas-
sie Brilliant Blue (CBB). The visualized bands were subjected to N-
terminal amino acid sequencing using protein sequencers G1005A
(Hewlett Packard, Palo Alto, CA, USA) and/or Procise 492cLC (Ap-
plied Biosystems).
2.6. Puri¢cation of natural Der p 1 and Der f 1
Natural Der p 1 and Der f 1 were puri¢ed from the whole culture
extracts from house dust mites, D. pteronyssinus and D. farinae, re-
spectively, as described previously by Yasueda et al. [5,6]
2.7. Measurement of proteolytic activity
Cysteine protease activity was measured as described previously [44]
with modi¢cations. Assays were conducted in reaction bu¡er (50 mM
sodium phosphate bu¡er, pH 7.0, containing 1 mM EDTA) with or
without 1 mM dithiothreitol (DTT) at 37‡C. Final concentrations of
the recombinant or natural allergens were 100 nM. The substrate
butyloxycarbonyl-Gln-Ala-Arg-MCA (Boc-Gln-Ala-Arg-MCA) (Pep-
tide Institute, Osaka, Japan) was used at 0.1 mM. The £uorescence of
aminomethylcoumarin released from the substrate was measured at an
excitation of 355 nm and emission of 460 nm on a £uorometer, Fluo-
roskan Ascent (Labsystems, Vantaa, Finland).
2.8. Radioallergosorbent test-enzyme immunoassay (RAST-EIA)
IgE reactivities were measured by radioallergosorbent test-enzyme
immunoassay (RAST-EIA) using a RAST-EIA Kit (Pharmacia, Pea-
pack, NJ, USA) as previously described [24]. Brie£y, serum of each
allergic patient (1/8 dilution) was incubated with paper discs coupled
with the allergens. Then, the IgE that bound to the disc was detected
with L-galactosidase-conjugated anti-human IgE antibodies by mea-
suring the £uorescence at an excitation of 355 nm and emission of 460
nm on the £uorometer. The mite-allergic patients’ sera were kindly
provided by Dr. Hirokazu Okudaira, Tokyo University.
3. Results
3.1. Cloning of cDNAs encoding for prepro-Der p 1 and
prepro-Der f 1
The cDNAs encoding for prepro-Der p 1 and prepro-Der f
1 were cloned by RT-PCR. Polymorphism was found in the
nucleotide sequences of the ORF of the clones. The amino
acid sequence of the prepro-Der p 1 clone selected for expres-
sion in this study was identical with that previously reported
as ‘clone (c)’ by Chua et al. [33] except for one residue (395 in
the signal sequence). The amino acid residue at position 395
was threonine in this isoform of prepro-Der p 1, whereas it
was valine in ‘clone (c)’ reported by Chua et al. The amino
acid sequence of the prepro-Der f 1 clone selected for expres-
sion in this study was identical with that previously reported
by Yasuhara et al. [34].
3.2. Preparation of puri¢ed recombinant and natural types of
Der p 1 and Der f 1
The prepro-Der p 1 and prepro-Der f 1 with original mite
amino acid sequences (Fig. 1A), prepro-Der p 1-WT and pre-
pro-Der f 1-WT, and their mutants whose N-glycosylation
motif within the mature sequences was disrupted by the sub-
stitution of an asparagine residue in the motif to a glutamine
residue, prepro-Der p 1-N52Q and prepro-Der f 1-N53Q,
were expressed. The proforms were secreted into culture me-
dium, and processed to mature forms by the methods de-
scribed in Materials and methods. Processing of the proforms
was checked by SDS^PAGE before the anion exchange chro-
matography. Essentially, all the allergen was processed during
dialysis against the acidic bu¡er. The amounts of puri¢ed
recombinant products per 1 l of BMMY medium were 80^
400 mg of pro-Der p 1-WT and pro-Der f 1-WT, 60^210 mg
of mature Der p 1-WT and Der f 1-WT, 15^70 mg of pro-Der
p 1-N52Q and pro-Der f 1-N53Q, and 10^40 mg of mature
Der p 1-N52Q and Der f 1-N53Q.
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The results of SDS^PAGE of puri¢ed recombinant forms of
Der p 1 and Der f 1 are shown in Fig. 1B. Two bands were
observed in the lane for pro-Der p 1-N52Q. The bands for
recombinant proteins with an N-glycosylation motif in the
mature sequence showed as smears (Der p 1-WT, pro-Der
p1-WT, Der f 1-WT, and pro-Der f 1-WT). Mobilities of
the mature forms under reducing conditions were signi¢cantly
less than those under non-reducing conditions. Mobilities of
the proforms under reducing conditions were equivalent to or
slightly less than those under non-reducing conditions. Ap-
proximate apparent molecular weights based on the mobilities
of the bands on the SDS^PAGE under non-reducing condi-
tions were 24 kDa for mature Der p 1-N52Q and Der f 1-
N53Q, 31 kDa and 33 kDa for pro-Der p 1-N52Q, 31 kDa for
pro-Der f 1-N53Q, 35^45 kDa for mature Der p 1-WT and
Der f 1-WT, and 50^70 kDa for pro-Der p 1-WT and pro-Der
f 1-WT. Those under reducing conditions were 27 kDa for
mature Der p 1-N52Q and Der f 1-N53Q, 32 kDa and 34
kDa for pro-Der p 1-N52Q, 32 kDa for pro-Der f 1-N53Q,
40^50 kDa for mature Der p 1-WT and Der f 1-WT, and 50^
70 kDa for pro-Der p 1-WT and pro-Der f 1-WT.
The mobilities on SDS^PAGE of mature Der p 1-N52Q
and Der f 1-N53Q were compared with those of natural
Der p 1 and Der f 1 (Fig. 1C). The mobilities of the recombi-
nant mature forms without the N-glycosylation expressed in
yeast were equivalent to those of the natural allergens puri¢ed
from mites.
3.3. N-terminal sequencing of recombinant pro- and mature
forms of Der p 1 and Der f 1
The samples of puri¢ed recombinant pro- and mature
forms of Der p 1 and Der f 1 were electrophoresed and elec-
troblotted, and the bands visualized by CBB-staining were
subjected to N-terminal sequencing. The results are summa-
rized in Fig. 2.
The N-terminal sequences of the four mature forms (Der p
1-N52Q, Der p 1-WT, Der f 1-N53Q, and Der f 1-WT) were
determined to start from 32 or 1, two-residues upstream from
or at the N-terminus of the natural ones (Fig. 2A,B). How-
ever, the ratios of the peaks corresponding to these two se-
quences in the four recombinant variants were di¡erent from
one another (Fig. 2D). The contents of the peaks correspond-
ing to the sequence starting from the N-terminus of the nat-
ural ones were only trace amounts in Der p 1-N52Q and
minor amounts in Der p 1-WT.
The N-terminal sequences of the two proforms of Der p 1
Fig. 1. Recombinant and natural types of the major house dust mite group 1 allergens Der p 1 and Der f 1. A: Schematic representation of
prepro-Der p 1 and prepro-Der f 1 expressed in this study, which have the original mite amino acid sequences. B: Puri¢ed recombinant forms
of Der p 1 and Der f 1. Proforms were puri¢ed from concentrated supernatants of yeast P. pastoris by column chromatography. Mature forms
were prepared from the proforms in concentrated supernatants by dialysis against an acidic bu¡er and puri¢ed by column chromatography.
They were subjected to SDS^PAGE (15^25%) and stained with CBB. Non-reducing and reducing: samples were boiled in the absence and pres-
ence of 2-mercaptoethanol in the sample bu¡er, respectively. C: Comparison of recombinant mature forms without N-glycosylation, Der p 1-
N52Q and Der f 1-N53Q, and natural types of Der p 1 and Der f 1. Natural types of Der p 1 and Der f 1 were puri¢ed from mites. Mature:
mature form; pro: proform; M: molecular weight marker; N52Q and N53Q: mutation of Asn in the N-glycosylation motif within the mature
sequence to Gln; WT: wild-type sequence.
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(pro-Der p 1-N52Q and pro-Der p 1-WT) were determined to
mainly start from 380, which was just after the putative sig-
nal-cleavage site in the original mite prepro-Der p 1 sequence
(Fig. 2A,E). Peaks corresponding to the sequence starting
from 361, which was 19 residues downstream from the puta-
tive signal-cleavage site and 4 residues downstream from the
N-glycosylation site in the prosequence of Der p 1, Asn (365),
were also observed but there were only trace amounts in pro-
Der p 1-N52Q and minor amounts in pro-Der p 1-WT. The
N-terminal sequences for the two major bands for pro-Der p
1-N52Q corresponding to 31 kDa and 33 kDa on SDS^PAGE
under non-reducing conditions, or 32 kDa and 34 kDa under
reducing conditions, were identical.
The N-terminal sequences of the proforms of Der f 1 (pro-
Der f 1-N53Q and pro-Der f 1-WT) were determined to start
from 380, which was just after the putative signal-cleavage
site in the original mite prepro-Der f 1 sequence, and also
from 359, which was 21 residues downstream from the puta-
tive signal-cleavage site (Fig. 2B,E).
3.4. Cysteine protease activities of natural and recombinant
forms of Der p 1 and Der f 1
The proteolytic activities of a total of ten variants of puri-
¢ed natural forms and recombinant pro- and mature forms of
Der p 1 and Der f 1 were analyzed in the presence or absence
of DTT, which activates the catalytic site of cysteine proteases
(Fig. 3A). The natural allergens (natural Der p 1 and natural
Der f 1) and the four recombinant mature forms (Der p 1-
N52Q, Der p 1-WT, Der f 1-N53Q, and Der f 1-WT) retained
their activities in the presence of DTT but did not in the
absence of DTT. Those of the two proforms of Der p 1
(pro-Der p 1-N52Q and pro-Der p 1-WT) were very low in
the presence of DTT and not detectable in the absence of
DTT. The two proforms of Der f 1 (pro-Der f 1-N53Q and
pro-Der f 1-WT) retained higher protease activities than the
proforms of Der p 1, although they were immature compared
with their mature forms in the presence of DTT (Fig. 3B), and
showed no activities in the absence of DTT.
3.5. IgE-binding of natural and recombinant mature forms of
Der p 1 and Der f 1
Patient IgE-binding pro¢les of recombinant mature forms
of Der p 1 and Der f 1 were determined by RAST-EIA (Fig.
4). In sera from two mite-allergic patients, the recombinant
mature Der p 1 (Der p 1-WT and Der p 1-N52Q) and Der f 1
(Der f 1-WT and Der f 1-N53Q) with or without the N-gly-
cosylation showed IgE-binding curves equivalent to those of
natural Der p 1 and Der f 1, respectively (Fig. 4A). Using
thirty or twenty-seven individual sera from mite-allergic pa-
tients, IgE-binding to recombinant Der p 1-N52Q or Der f 1-
N53Q, which lacked the yeast-derived N-glycosylation, was
compared with that of natural Der p 1 or Der f 1 puri¢ed
from mites, respectively (Fig. 4BC). Close correlations of IgE-
binding between natural Der p 1 and recombinant Der p 1-
Fig. 2. N-terminal amino acid sequencing of puri¢ed recombinant pro- and mature forms of the major house dust mite group 1 allergens Der
p 1 and Der f 1. Schematic representation of N-terminal amino acid residues of recombinant pro- and mature forms of Der p 1 in this study
(A), Der f 1 in this study (B), and Der f 1 in our previous report [35] (C), and approximate molecular ratios of variations in the di¡erent N-
terminal sequences of the mature forms (D) and the proforms (E) are shown. In A and B, mite-derived original amino acid sequences were
used. In C, yeast Pichia-derived PHO1 signal sequence was fused to the mite prosequence. The bold type indicates mutation as a result of in-
troducing a restriction site, and the sequence in the previous report [35] is revised here. Underlined: putative signal sequence for secretion;
boxed: N-glycosylation motif. In D and E, the ratios were approximately estimated from the peak heights of HPLC in the protein sequencing.
N52Q and N53Q: mutation of Asn in the N-glycosylation motif within the mature sequence to Gln; WT: wild-type sequence; Trace: peaks
corresponding to the sequence starting from the N-terminus were detected as only a trace.
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N52Q (R2 = 0.9805, P6 0.0001) (Fig. 4B) and between natural
Der f 1 and recombinant Der f 1-N53Q (R2 = 0.9877,
P6 0.0001) (Fig. 4C) were observed.
4. Discussion
The ¢rst reports of activation of a recombinant house dust
mite group 1 allergen were made by Shoji et al. [45,46], in
which recombinant pro-Der f 1 secreted by insect SF9 cells
was converted to active prosequence-removed Der f 1 by dial-
ysis against an acidic bu¡er. Recently, we also demonstrated
that proforms of Der f 1 secreted by yeast P. pastoris cells
matured to the enzymatically active mature forms [35]. How-
ever, concerning Der p 1, recombinant forms of pro-Der p 1
secreted by insect Drosophila cells [38] and mammalian CHO
cells [39] were not convertible to enzymatically active mature
forms and, very recently, van Oort et al. [40] reported that
pro-Der p 1 secreted by P. pastoris with yeast-derived hetero-
geneous sugar chains was not spontaneously processed, while
Jacquet et al. [41] reported the activation of the highly glyco-
sylated form. Some molecular mechanisms might underlie
such discrepancies between the results in these trials to obtain
active recombinant forms of Der f 1 and Der p 1. Therefore,
the purposes of our study were not only to establish a system
for the preparation of active Der p 1 with properties equiv-
alent to natural Der p 1, but also to provide some insights
into the molecular mechanisms in processing, activation, and/
or inhibition of maturation of the proforms of the two house
dust mite group 1 allergens by comparing the di¡erences in
properties among the recombinant products.
We used completely mite-derived amino acid sequences of
prepro-Der p 1 and prepro-Der f 1 for the expression in this
study (Figs. 1A, 2A,B), while a Pichia-derived signal sequence
was used in our previous report [35] for secretion of pro-Der f
1 (Fig. 2C). The N-glycosylation of the wild-type mature se-
quences of both Der p 1 and Der f 1 in Pichia cells leads to
heterogeneous glycosylation (Fig. 1B, Der p 1-WT, Der f 1-
WT). Pro-Der p 1-N52Q without N-glycosylation in the ma-
ture sequence showed two major bands on SDS^PAGE (Fig.
1B, Der p 1-N52Q, Pro). This is considered a result of di¡er-
ential modi¢cations of the N-glycosylation motif in the Der p
1 prosequence (Figs. 1A, 2A), which does not exist in the Der
f 1 prosequence, on the basis of the results of N-terminal
sequencing (Fig. 2E), SDS^PAGE showing a single band for
the mature form (Fig. 1B, Der p 1-N52Q, Mature), and anal-
ysis of the amino acid compositions (data not shown). Signi¢-
Fig. 3. Proteolytic activities of puri¢ed recombinant and natural types of the major house dust mite group 1 allergens Der p 1 and Der f 1. A:
Time courses of digestion of Boc-Gln-Ala-Arg-MCA. The values are calculated by subtracting the background of the substrate, and the initial
values from the original values are shown. B: Relative proteolytic activities of the recombinant proforms to that of Der f 1-WT. The values
are calculated from £uorescence intensities in the presence of DTT at 24 min. N52Q and N53Q: mutation of Asn in the N-glycosylation motif
within the mature sequence to Gln; WT: wild-type sequence; mature: mature form; pro: proform; DTT+ and DTT-: the reaction was per-
formed in the presence and absence of DTT, respectively.
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cantly higher mobility of the mature forms on SDS^PAGE
under non-reducing conditions than under reducing condi-
tions is considered a result of the formation of intramolecular
disul¢de bonds of Der p 1 and Der f 1 [36] (Fig. 1B, Mature).
In the mature forms, almost all of the prosequence was re-
moved (Fig. 2A,B,D), and both cysteine protease (Fig. 3A)
and IgE-binding (Fig. 4) activities were fully retained. The
activated recombinant mature forms are considered to be
folded and biologically functional. To obtain recombinant
proteins more closely resembling natural ones, we generated
mutants in which the N-glycosylation motif within the mature
sequence was disrupted. The mutants showed no smear bands
on SDS^PAGE (Fig. 1B, Der p 1-N52Q, Der f 1-53Q) and the
mature forms of the mutants retained an apparent molecular
weight equivalent to the natural ones (Fig. 1C). These re-
combinant mature house dust mite group 1 allergens with
the same properties as the natural types will be useful tools
for diagnosis, standardized AIT [18^20], and various other
studies, as well as the major house dust mite group 2 allergen
from D. farinae, Der f 2, which we have investigated as a
model allergen for allergen engineering [21^29].
All the visible bands stained after electroblotting were sub-
jected to N-terminal sequencing and variation in the N-termi-
nal sequences existed in the puri¢ed recombinant samples
(Fig. 2A,B,D,E). Interestingly, the proforms of Der p 1 and
Der f 1 di¡ered in the N-terminal sequences (Fig. 2A,B,E) and
the proteolytic activity (Fig. 3). While the N-termini of the
proforms of Der p 1 (pro-Der p 1-WT and pro-Der p 1-
N52Q) mainly started just after the putative signal-cleavage
site, the proforms of Der f 1 (pro-Der f 1-WT and pro-Der f
1-N53Q) had those starting not only from the equivalent site
but 21 residues downstream (Fig. 2A,B,E), and retained high-
er activity than the proforms of Der p 1 (Fig. 3). The ratios of
partial digestion before position 361 in pro-Der p 1 or 359 in
pro-Der f 1 correlated with the proteolytic activities of the
proforms (Fig. 2E, Fig. 3B). These results raised two ques-
tions. Firstly, why did the di¡erence in the ratio of the partial
digestion correlate with the enzymatic activity of the pro-
forms? Secondly, why did the proforms of Der f 1 show high-
er ratios of partial digestion than those of Der p 1?
The prosequence of protease is considered to help in correct
folding of the precursor suitable for mature folding of the
prosequence-removed active protease, and to maintain the
protease inactive until transfer and exposure to sites or situa-
tions where the protease could be sorted and function. As an
answer to the ¢rst question, we consider that the N-terminal
regions of Der p 1 and Der f 1 have a role in blocking the
proteolytic activity e¡ectively and/or that removal of the 18 or
20 amino acid sequence in the prosequences of Der p 1 or Der
f 1 leads to partial activation of the proforms. This consider-
ation correlates well with recent reports by two groups on the
maturation of pro-Der p 1 with the yeast-derived heteroge-
neous sugar chain secreted by P. pastoris, although their re-
sults were di¡erent from each other, i.e., van Oort et al. [40]
Fig. 4. IgE-binding activities of recombinant mature forms and natural types of the major house dust mite group 1 allergens Der p 1 and Der
f 1. Paper discs to which allergen was coupled were incubated with diluted mite-allergic patients’ sera and IgE that bound to the discs was de-
tected with L-galactosidase-conjugated anti-human IgE antibodies by measuring the £uorescence. A: IgE-binding pro¢les of recombinant mature
forms with and without yeast-derived N-glycosylation, and natural types of Der p 1 and Der f 1 in two sera. B: Correlation between the IgE
reactivity of recombinant mature Der p 1-N52Q without yeast-derived N-glycosylation and natural Der p 1. Thirty sera were tested. The con-
centration of the allergens in the immobilization step was 75 nM. C: Correlation between the IgE reactivity of recombinant mature Der f 1-
N53Q without yeast-derived N-glycosylation and natural Der f 1. Twenty-seven sera were tested. The concentration of the allergens in the im-
mobilization step was 25 nM. N52Q and N53Q: mutation of Asn in the N-glycosylation motif within the mature sequence to Gln; WT: wild-
type sequence. The values calculated by subtracting the background of the paper discs without coupling of allergen from the original values are
shown.
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reported that the pro-Der p 1-WT with N-terminus just after
the putative signal-cleavage site was mainly obtained and not
spontaneously processed, while Jacquet et al. [41] reported
that the pro-Der p 1-WT with N-terminus of 19 residues
downstream of the putative-cleavage site was obtained and
successfully processed to the active mature form. Our results
showing that pro-Der p 1-N52Q and pro-Der p 1-WT with
the N-terminus just after the putative signal-cleavage site were
mainly obtained and processed to the active mature forms was
intermediate between those by the two groups. The di¡erences
among the three studies could be attributable to di¡erences in
procedures for maturation and/or origins of the signal sequen-
ces fused to the proforms for secretion.
As an answer to the second question, we suspect that N-
glycosylation of the Der p 1 prosequence might be a reason
for the higher ratios of partial digestion in pro-Der f 1 than in
pro-Der p 1. Interestingly, the minor N-terminus of the pro-
forms of Der p 1 in this study, Ala (361), is only 4 residues
downstream from the N-glycosylation site in the Der p 1
prosequence, Asn (365) (Fig. 1A, Fig. 2A). Therefore, diges-
tion near Asn (365) might be inhibited by the sugar chain
attachment in pro-Der p 1 di¡ering from pro-Der f 1. E¡ects
of the sugar chain in the prosequence on folding and/or in-
teraction between the prosequence and mature portion might
also be possible. This hypothesis could also explain the di⁄-
culty in preparing enzymatically active recombinant mature
Der p 1 compared to Der f 1 in the previous reports [38^
40]. Molecular mechanisms of processing, activation, and/or
inhibition of maturation of the proforms should be analyzed
in further studies.
In this study, we demonstrated for the ¢rst time the prep-
aration of recombinant mature Der p 1, Der p 1-N52Q, which
has no yeast-derived N-glycosylation and retains an apparent
molecular weight equivalent to natural Der p 1, with full
enzymatic and IgE-binding activities. The recombinant ma-
ture house dust mite group 1 allergens prepared in this study
with the same properties as the natural types will be the basis
of various studies. Moreover, by comparing the properties of
the recombinant pro- and mature forms of the two homolo-
gous allergens Der p 1 and Der f 1, we suggested the contri-
bution of the N-terminal region of the Der p 1 prosequence
including the N-glycosylation site, Asn (365), on e¡ective in-
hibition of proteolytic activity in pro-Der p 1. This region
should be a target candidate for the manipulation of proteo-
lytic activities of recombinant variants. Such variants are con-
sidered useful as allergen vaccines because the proteolytic ac-
tivity of Der p 1 has been proposed to be involved in the
pathogenesis of allergies [13^17,30]. The ¢ndings in this study
implicate a method for e¡ective blockade of the harmful pro-
teolytic activity of the major house dust mite group 1 aller-
gens.
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